{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:32:55Z","timestamp":1789471975974,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T00:00:00Z","timestamp":1475193600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00417-016-3497-5","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T21:49:05Z","timestamp":1475185745000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis"],"prefix":"10.1007","volume":"255","author":[{"given":"Marc","family":"Breitbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Tappeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R. R.","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Zurek-Imhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solon","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Heiligenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,30]]},"reference":[{"key":"3497_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"3497_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/bjo.2004.050609","volume":"89","author":"D BenEzra","year":"2005","unstructured":"BenEzra D, Cohen E, Maftzir G (2005) Uveitis in children and adolescents. Br J Ophthalmol 89:444\u2013448. doi: 10.1136\/bjo.2004.050609","journal-title":"Br J Ophthalmol"},{"key":"3497_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00417-005-0087-3","volume":"244","author":"PE Carvounis","year":"2006","unstructured":"Carvounis PE, Herman DC, Cha S et al (2006) Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol 244:281\u2013290. doi: 10.1007\/s00417-005-0087-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3497_CR4","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/acr.22613","volume":"67","author":"I Foeldvari","year":"2015","unstructured":"Foeldvari I, Becker I, Horneff G (2015) Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the Biologics in Pediatric Rheumatology Registry. Arthritis Care Res (Hoboken) 67:1529\u20131535. doi: 10.1002\/acr.22613","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3497_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3109\/09273948.2013.791701","volume":"21","author":"A Heiligenhaus","year":"2013","unstructured":"Heiligenhaus A, Heinz C, Edelsten C et al (2013) Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 21:180\u2013191. doi: 10.3109\/09273948.2013.791701","journal-title":"Ocul Immunol Inflamm"},{"key":"3497_CR6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0161-6420(01)00773-4","volume":"108","author":"K Kotaniemi","year":"2001","unstructured":"Kotaniemi K, Kautiainen H, Karma A et al (2001) Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology 108:2071\u20132075","journal-title":"Ophthalmology"},{"key":"3497_CR7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Niewerth M, Ganser G et al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford, England) 46:1015\u20131019. doi: 10.1093\/rheumatology\/kem053","journal-title":"Rheumatology (Oxford, England)"},{"key":"3497_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.86.1.51","volume":"86","author":"C Edelsten","year":"2002","unstructured":"Edelsten C, Lee V, Bentley CR et al (2002) An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 86:51\u201356","journal-title":"Br J Ophthalmol"},{"key":"3497_CR9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0002-9394(02)02148-7","volume":"135","author":"C Edelsten","year":"2003","unstructured":"Edelsten C, Reddy MA, Stanford MR et al (2003) Visual loss associated with pediatric uveitis in english primary and referral centers. Am J Ophthalmol 135:676\u2013680","journal-title":"Am J Ophthalmol"},{"key":"3497_CR10","doi-asserted-by":"publisher","unstructured":"Sijssens KM, Rothova A, Berendschot TTJM et al (2006) Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology 113:853\u2013859.e2. doi: 10.1016\/j.ophtha.2006.01.043","DOI":"10.1016\/j.ophtha.2006.01.043"},{"key":"3497_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR et al (2007) Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 143:840\u2013846. doi: 10.1016\/j.ajo.2007.01.033","journal-title":"Am J Ophthalmol"},{"key":"3497_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","volume":"120","author":"AC Gregory","year":"2013","unstructured":"Gregory AC, Kempen JH, Daniel E et al (2013) Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology 120:186\u2013192. doi: 10.1016\/j.ophtha.2012.07.052","journal-title":"Ophthalmology"},{"key":"3497_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/09273948.2013.871566","volume":"23","author":"J Boer de","year":"2015","unstructured":"de Boer J, Steijaert A, van den Bor R et al (2015) Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis. Ocul Immunol Inflamm 23:67\u201373. doi: 10.3109\/09273948.2013.871566","journal-title":"Ocul Immunol Inflamm"},{"key":"3497_CR14","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/acr.21674","volume":"64","author":"A Heiligenhaus","year":"2012","unstructured":"Heiligenhaus A, Foeldvari I, Edelsten C et al (2012) Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res (Hoboken) 64:1365\u20131372. doi: 10.1002\/acr.21674","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3497_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","volume":"35","author":"R Bou","year":"2015","unstructured":"Bou R, Ad\u00e1n A, Borr\u00e1s F et al (2015) Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int 35:777\u2013785. doi: 10.1007\/s00296-015-3231-3","journal-title":"Rheumatol Int"},{"key":"3497_CR16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","volume":"32","author":"A Heiligenhaus","year":"2012","unstructured":"Heiligenhaus A, Michels H, Schumacher C et al (2012) Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int 32:1121\u20131133","journal-title":"Rheumatol Int"},{"key":"3497_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/acr.22214","volume":"66","author":"G Simonini","year":"2014","unstructured":"Simonini G, Druce K, Cimaz R et al (2014) Current evidence of anti-tumor necrosis factor \u03b1 treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs. Arthritis Care Res 66:1073\u20131084. doi: 10.1002\/acr.22214","journal-title":"Arthritis Care Res"},{"key":"3497_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","volume":"149","author":"LB Vazquez-Cobian","year":"2006","unstructured":"Vazquez-Cobian LB, Flynn T, Lehman TJA (2006) Adalimumab therapy for childhood uveitis. J Pediatr 149:572\u2013575. doi: 10.1016\/j.jpeds.2006.04.058","journal-title":"J Pediatr"},{"key":"3497_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"S Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H et al (2007) Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 91:319\u2013324. doi: 10.1136\/bjo.2006.103721","journal-title":"Br J Ophthalmol"},{"key":"3497_CR20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT et al (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"3497_CR21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/ard.57.1.38","volume":"57","author":"N Ruperto","year":"1998","unstructured":"Ruperto N, Ravelli A, Falcini F, Italian Pediatric Rheumatology Study Group et al (1998) Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Ann Rheum Dis 57:38\u201341","journal-title":"Ann Rheum Dis"},{"key":"3497_CR22","first-page":"1146","volume":"34","author":"I Foeldvari","year":"2007","unstructured":"Foeldvari I, Nielsen S, K\u00fcmmerle-Deschner J et al (2007) Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34:1146\u20131150","journal-title":"J Rheumatol"},{"key":"3497_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2147\/OPTH.S23646","volume":"5","author":"K Kotaniemi","year":"2011","unstructured":"Kotaniemi K, S\u00e4il\u00e4 H, Kautiainen H (2011) Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis. Clin Ophthalmol 5:1425\u20131459. doi: 10.2147\/OPTH.S23646","journal-title":"Clin Ophthalmol"},{"key":"3497_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/bjophthalmol-2013-303935","volume":"98","author":"D Doycheva","year":"2014","unstructured":"Doycheva D, Zierhut M, Blumenstock G et al (2014) Immunomodulatory therapy with tumour necrosis factor \u03b1 inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol 98:523\u2013528. doi: 10.1136\/bjophthalmol-2013-303935","journal-title":"Br J Ophthalmol"},{"key":"3497_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/rheumatology\/kem356","volume":"47","author":"P Tynj\u00e4l\u00e4","year":"2008","unstructured":"Tynj\u00e4l\u00e4 P, Kotaniemi K, Lindahl P et al (2008) Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology (Oxford, England) 47:339\u2013344. doi: 10.1093\/rheumatology\/kem356","journal-title":"Rheumatology (Oxford, England)"},{"key":"3497_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00417-013-2275-x","volume":"251","author":"A Magli","year":"2013","unstructured":"Magli A, Forte R, Navarro P et al (2013) Adalimumab for juvenile idiopathic arthritis-associated uveitis. Graefes Arch Clin Exp Ophthalmol 251:1601\u20131606. doi: 10.1007\/s00417-013-2275-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3497_CR27","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/acr.20404","volume":"63","author":"G Simonini","year":"2011","unstructured":"Simonini G, Taddio A, Cattalini M et al (2011) Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res 63:612\u2013618. doi: 10.1002\/acr.20404","journal-title":"Arthritis Care Res"},{"key":"3497_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3899\/jrheum.120583","volume":"40","author":"ME Zannin","year":"2013","unstructured":"Zannin ME, Birolo C, Gerloni VM et al (2013) Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. J Rheumatol 40:74\u201379. doi: 10.3899\/jrheum.120583","journal-title":"J Rheumatol"},{"key":"3497_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1546-0096-11-16","volume":"11","author":"G Simonini","year":"2013","unstructured":"Simonini G, Taddio A, Cattalini M et al (2013) Superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: adalimumab as starting anti-TNF-\u03b1 therapy in childhood chronic uveitis. Pediatr Rheumatol Online J 11:16. doi: 10.1186\/1546-0096-11-16","journal-title":"Pediatr Rheumatol Online J"},{"key":"3497_CR30","doi-asserted-by":"publisher","first-page":"560632","DOI":"10.1155\/2013\/560632","volume":"2013","author":"C Garc\u00eda-De-Vicu\u00f1a","year":"2013","unstructured":"Garc\u00eda-De-Vicu\u00f1a C, D\u00edaz-Llopis M, Salom D et al (2013) Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. Mediat Inflamm 2013:560632. doi: 10.1155\/2013\/560632","journal-title":"Mediat Inflamm"},{"key":"3497_CR31","doi-asserted-by":"publisher","unstructured":"Lerman MA, Lewen MD, Kempen JH et al (2015) Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol 160:193\u2013200.e1. doi: 10.1016\/j.ajo.2015.04.016","DOI":"10.1016\/j.ajo.2015.04.016"},{"key":"3497_CR32","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/art.38741","volume":"66","author":"H Schmeling","year":"2014","unstructured":"Schmeling H, Minden K, Foeldvari I et al (2014) Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry. Arthritis Rheumatol 66:2580\u20132589. doi: 10.1002\/art.38741","journal-title":"Arthritis Rheumatol"},{"key":"3497_CR33","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/rheumatology\/keu457","volume":"54","author":"M Tarkiainen","year":"2015","unstructured":"Tarkiainen M, Tynj\u00e4l\u00e4 P, V\u00e4h\u00e4salo P et al (2015) Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting. Rheumatology (Oxford, England) 54:1170\u20131176. doi: 10.1093\/rheumatology\/keu457","journal-title":"Rheumatology (Oxford, England)"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3497-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:01:03Z","timestamp":1498334463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3497-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["3497"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3497-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,30]]}}}